Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China—Study Design and Baseline Characteristics-Reference-Cited by-同舟云学术

Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China—Study Design and Baseline Characteristics

Published:2015-10 Issue:10 Volume:17 Page:735-744
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Ji Linong¹²,Zhang Puhong²,Weng Jianping³,Lu Juming⁴,Guo Xiaohui¹,Jia Weiping⁵,Yang Wenying⁶,Zou Dajin⁷,Zhou Zhiguang⁸,Pan Changyu⁹,Gao Yan¹,Li Xian²,Zhu Dongshan²,Li Ying²,Wu Yangfeng²,Garg Satish K.¹⁰

Affiliation:

1. Peking University People's Hospital, Beijing, China.

2. The George Institute for Global Health at Peking University Health Science Center, Beijing, China.

3. The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

4. Chinese PLA General Hospital, Beijing, China.

5. Shanghai 6th Hospital, Shanghai, China.

6. China-Japan Friendship Hospital, Beijing, China.

7. The Second Military Medical University, Shanghai, China.

8. Xiangya Second Hospital, Changsha, Hunan, China.

9. Beijing 301 Military General Hospital, Beijing, China.

10. Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado.

Publisher